Breast cancer (BC) is the most diagnosed cancer in women and the second leading cause of cancer death in women in the USA.1,2 Endocrine therapy (ET) is the most common treatment modality for BC patients with tumors that express hormone receptors (luminal subtype) and is initially quite effective. Here, NR4A1 is linked to breast cancer.